Denali Therapeutics Inc. (DNLI)
NASDAQ·Healthcare·Biotechnology
$19.93
-0.69%
Mkt Cap $3.03B
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (24 analysts)
$33.67
Range $26.00 – $41.00
Implied Upside
+68.9%
Consensus $33.67 vs current $19.93
NASDAQ·Healthcare·Biotechnology
$19.93
-0.69%
Mkt Cap $3.03B
Buy
9
Hold
0
Sell
0
Price Target (24 analysts)
$33.67
Range $26.00 – $41.00
+68.9%
Consensus $33.67 vs current $19.93